LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
NCT07100067
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed/Refractory Multiple Myeloma(MM)
Interventions
BIOLOGICAL:
LCAR- F33S cells intravenous infusion
Sponsor
Nanjing Legend Biotech Co.
Collaborators
[object Object]